SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023)

被引:0
|
作者
Alonso-Gordoa, Teresa [1 ]
Jimenez-Fonseca, Paula [2 ]
Martinez-Trufero, Javier [3 ]
Navarro, Miguel [4 ]
Porras, Ignacio [5 ]
Rubio-Casadevall, Jordi [6 ]
Arregui Valles, Marta [7 ]
Baste, Neus [8 ]
Hernando, Jorge [9 ]
Iglesias Docampo, Lara [10 ]
机构
[1] Hosp Univ Ramon & Cajal, Med Oncol Dept, Madrid, Spain
[2] Hosp Univ Cent Asturias, Med Oncol Dept, ISPA, Oviedo, Spain
[3] Hosp Univ Miguel Servet, Med Oncol Dept, Zaragoza, Spain
[4] Complejo Asistencial Univ Salamanca, Med Oncol Dept, IBSAL, Salamanca, Spain
[5] Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Med Oncol Dept, Cordoba, Spain
[6] Hosp Josep Trueta, Catalan Inst Oncol Girona, Girona Biomed Res Inst IDIBGI, Med Oncol Dept,ONCOGIRPRO Grp, Girona, Spain
[7] Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, Spain
[8] Hosp Clin Barcelona, Med Oncol Dept, IDIBAPS, Barcelona, Spain
[9] Hosp Univ Vall DHebron, Med Oncol Dept, Gastrointestinal & Endocrine Tumor Unit, VHIO, Barcelona, Spain
[10] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年 / 26卷 / 11期
关键词
Thyroid carcinoma; Molecular alterations; Multidisciplinary; Systemic treatment; PHASE-II TRIAL; ASSOCIATION GUIDELINES; DOUBLE-BLIND; LOCOREGIONAL RECURRENCE; RISK STRATIFICATION; NECK DISSECTION; OPEN-LABEL; CARCINOMA; MANAGEMENT; PAPILLARY;
D O I
10.1007/s12094-024-03736-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thyroid cancer (TC) represents 3% of global cancer incidence. Recent changes have optimized treatment decisions based on risk assessment, molecular profiling, and imaging assessment, leading the development of targeted agents that have modified the natural history of this disease. This increasing complexity on treatment options requires careful assessment at the different stages of the disease to provide the most suitable approach from diagnosis to long-term follow-up. This guideline aims to offer a comprehensive and practical overview on the current status and last updates of TC management.
引用
收藏
页码:2902 / 2916
页数:15
相关论文
共 50 条
  • [31] SEOM Clinical Guideline of localized rectal cancer (2016)
    Gonzalez-Flores, E.
    Losa, F.
    Pericay, C.
    Polo, E.
    Rosello, S.
    Safont, M. J.
    Vera, R.
    Aparicio, J.
    Cano, M. T.
    Fernandez-Martos, C.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (12): : 1163 - 1171
  • [32] SEOM Clinical Guideline for the treatment of pancreatic cancer (2016)
    R. Vera
    E. Dotor
    J. Feliu
    E. González
    B. Laquente
    T. Macarulla
    E. Martínez
    J. Maurel
    M. Salgado
    J. L. Manzano
    Clinical and Translational Oncology, 2016, 18 : 1172 - 1178
  • [33] SEOM clinical guidelines for the treatment of thyroid cancer
    Javier Martínez Trufero
    Jaume Capdevilla
    Juan Jesús Cruz
    Dolores Isla
    Clinical and Translational Oncology, 2011, 13 : 574 - 579
  • [34] SEOM clinical guidelines for the treatment of thyroid cancer
    Martinez Trufero, Javier
    Capdevilla, Jaume
    Jesus Cruz, Juan
    Isla, Dolores
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (08): : 574 - 579
  • [35] SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)
    Munoz Martin, A. J.
    Gallardo Diaz, E.
    Garcia Escobar, I
    Macias Montero, R.
    Martinez-Marin, V
    Pachon Olmos, V
    Perez Segura, P.
    Quintanar Verduguez, T.
    Salgado Fernandez, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (02): : 171 - 186
  • [36] SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)
    A. J. Muñoz Martín
    E. Gallardo Díaz
    I. García Escobar
    R. Macías Montero
    V. Martínez-Marín
    V. Pachón Olmos
    P. Pérez Segura
    T. Quintanar Verdúguez
    M. Salgado Fernández
    Clinical and Translational Oncology, 2020, 22 : 171 - 186
  • [37] Correction to: SEOM clinical guideline for treatment of kidney cancer (2017)
    E. Gallardo
    M. J. Méndez-Vidal
    J. L. Pérez-Gracia
    J. M. Sepúlveda-Sánchez
    M. Campayo
    I. Chirivella-González
    X. García-del-Muro
    A. González-del-Alba
    E. Grande
    C. Suárez
    Clinical and Translational Oncology, 2019, 21 : 692 - 693
  • [38] SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)
    María José Méndez-Vidal
    Martin Lázaro Quintela
    Nuria Lainez-Milagro
    Begoña Perez-Valderrama
    Cristina Suárez Rodriguez
    José Ángel Arranz Arija
    Ignacio Peláez Fernández
    Enrique Gallardo Díaz
    Julio Lambea Sorrosal
    Aránzazu González-del-Alba
    Clinical and Translational Oncology, 2023, 25 : 2732 - 2748
  • [39] SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016)
    M. Martin-Richard
    R. Díaz Beveridge
    V. Arrazubi
    M. Alsina
    M. Galan Guzmán
    A. B. Custodio
    C. Gómez
    F. L. Muñoz
    R. Pazo
    F. Rivera
    Clinical and Translational Oncology, 2016, 18 : 1179 - 1186
  • [40] SEOM SOGUG clinical guideline for treatment of kidney cancer (2022)
    Mendez-Vidal, Maria Jose
    Quintela, Martin Lazaro
    Lainez-Milagro, Nuria
    Perez-Valderrama, Begona
    Rodriguez, Cristina Suarez
    Arija, Jose Angel Arranz
    Fernandez, Ignacio Pelaez
    Diaz, Enrique Gallardo
    Sorrosal, Julio Lambea
    Gonzalez-del-Alba, Aranzazu
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (09): : 2732 - 2748